Cinarzin15 mg



Ibn-Sina Pharmaceuticals Ltd.

Product Code : 3502
MRP 1.00
10% Off
Best PriceTk

Medicine overview

Indications of Cinarzin 15 mg

It is mainly used for the symptomatic treatment of nausea and vertigo due to Meniere's disease and other labyrinthine disturbances and for the prevention and treatment of motion sickness. It is also used in the management of various vascular disorders.Cerebral circulatory disorders:... Read more

Theropeutic Class

Anti vertigo drugs


Cinarzin 15 mg acts as an antihistamine, labyrinthine sedative and a peripheral antivasoconstrictor. Cinarzin 15 mg is a selective calcium antagonist, inhibiting the influx of Ca2+ intracellularly. It prevents the Ca2+ dependent contraction of arterial smooth muscle by inhibiting Ca2+ influx through smooth muscle calcium channels and thereby, improves vestibular symptoms and prevents peripheral arterial disease

Dosage & Administration of Cinarzin 15 mg

Usual adult dose: 15 to 30 mg three times daily.Children (5 to 12 years): Half of the adult dose.Motion sickness: A dose of 30 mg two hours before the start of the journey and 15 mg every 8 hours during the journey.Peripheral arterial diseases: 75 mg two or three times daily.

Interaction of Cinarzin 15 mg

No drug interactions have been seen with Cinarzin 15 mg when administered concomitantly with antihypertensives, diuretics, anticoagulants or hypoglycaemics.


There are no specific contraindications. It has been found to decrease blood pressure significantly. However, the drug should be used with reasonable caution in hypotensive patients.

Side Effects of Cinarzin 15 mg

Side effects such as somnolence and gastrointestinal disturbances are extremely rare. They are transient and may be readily prevented by achieving the optimal dosage gradually. Allergic skin reactions and fatigue have been reported on rare occasions. An aggravation or appearance of extrapyramidal symptoms has been reported extremely rarely in elderly people during prolonged therapy. The treatment should be reduced or stopped in such cases.

Pregnancy & Lactation

The safety of Cinarzin 15 mg in human pregnancy has not been established although studies in animals have not demonstrated teratogenic effects. Therefore, it is not advisable to administer Cinarzin 15 mg in pregnancy

Precautions & Warnings

Cinarzin 15 mg may cause drowsiness; patients affected in this way should not drive or operate machinery. Avoid alcoholic drink.

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.